Open | $4.210 |
Close | $4.360 |
Volume / Avg. | 195.138K / 25.404K |
Day Range | 4.170 - 4.500 |
52 Wk Range | 2.220 - 5.050 |
Market Cap | $242.739M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 72 |
Short Interest | 0.24% |
Days to Cover | 3.39 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Inventiva (NASDAQ: IVA) through any online brokerage.
Other companies in Inventiva’s space includes: Innate Pharma (NASDAQ:IPHA), Graphite Bio (NASDAQ:GRPH), FibroGen (NASDAQ:FGEN), Gritstone Bio (NASDAQ:GRTS) and Mesoblast (NASDAQ:MESO).
The latest price target for Inventiva (NASDAQ: IVA) was reported by HC Wainwright & Co. on Friday, March 8, 2024. The analyst firm set a price target for 22.00 expecting IVA to rise to within 12 months (a possible 368.09% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Inventiva (NASDAQ: IVA) is $4.7 last updated March 18, 2024 at 7:58 PM EDT.
There are no upcoming dividends for Inventiva.
Inventiva’s FY earnings are confirmed for Monday, April 1, 2024.
There is no upcoming split for Inventiva.
Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.